Tg Therapeutics (TGTX) Asset Utilization Ratio (2018 - 2026)

Tg Therapeutics (TGTX) posted quarterly Asset Utilization Ratio of 0.54 for Q1 2026, down 13.68% year-over-year from 0.63 in Q1 2025, and down 8.45% quarter-over-quarter from 0.59 in Q4 2025.

Tg Therapeutics (TGTX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Tg Therapeutics' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.54 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 13.68% year-over-year to 0.54; the TTM figure through Mar 2026 stood at 0.54 (down 13.68% YoY), while the FY2025 annual figure was 0.75, up 3.57% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.54, down from 0.59 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.9 in Q2 2024, with the low at 0.01 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.57 (2024), against an average of 0.44.
  • The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 5127.3% in 2023, then dropped 25.38% in 2025.
  • Tg Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then jumped by 5127.3% to 0.71 in 2023, then dropped by 20.06% to 0.57 in 2024, then advanced by 4.38% to 0.59 in 2025, then fell by 8.45% to 0.54 in 2026.
  • Business Quant data shows TGTX's Asset Utilization Ratio at 0.54 in Q1 2026, 0.59 in Q4 2025, and 0.62 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.38
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.69
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 186.67
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.13
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.90
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.54
10 Tg Therapeutics 7.46 Bn 6.78 Bn 199.14 Mn 0.50

Historic Data

Download Data
DateValue
Jun 30, 2026 0.50
Mar 31, 2026 0.54
Dec 31, 2025 0.59
Sep 30, 2025 0.62
Jun 30, 2025 0.67
Mar 31, 2025 0.63
Dec 31, 2024 0.57
Sep 30, 2024 0.54
Jun 30, 2024 0.90
Mar 31, 2024 0.82
Dec 31, 2023 0.71
Sep 30, 2023 0.69
Jun 30, 2023 0.12
Mar 31, 2023 0.04
Dec 31, 2022 0.01
Sep 30, 2022 0.02
Jun 30, 2022 0.03
Mar 31, 2022 0.02
Dec 31, 2021 0.02
Sep 30, 2021 0.01